全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2016 

N-乙酰半胱氨酸对异烟肼和利福平联合应用所致小鼠肝损伤保护作用 Protective the Treatment with Effect of N-acetylcysteine on Hepatic Damage Induced by the Combination of Isoniazid and Rifampicin in Mice

Keywords: N-乙酰半胱氨酸,异烟肼,利福平,损伤,肝脏保护,脂质过氧化

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨N-乙酰半胱氨酸对异烟肼和利福平联用所致小鼠肝损伤的保护作用及其可能机制。方法:32只昆明鼠随机分为4组(每组8只)后给予如下治疗:腹腔注射异烟肼和利福平(肝损伤组)、腹腔注射N-乙酰半胱氨酸(NAC)30min后再腹腔注射异烟肼和利福平(NAC保护组)、腹腔注射NAC(NAC对照组)和腹腔注射生理盐水(对照组)。治疗14d后处死小鼠,取眼球血,测量血清谷氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)活性;取小鼠肝组织并测量肝指数(肝指数=肝重/体重),部分肝组织常规石蜡包埋切片,光镜观察肝组织形态结构特征;部分肝组织均浆,检测其中丙二醛(MDA)含量及超氧化物歧化酶(SOD)活性。结果:肝损伤组小鼠肝细胞呈不同程度的水变性和脂肪变性及局灶性坏死溶解,NAC保护组小鼠肝细胞呈轻度水变性和脂肪变性,未见肝细胞坏死。肝损伤组及NAC保护组小鼠肝指数(64.38±0.63及60.54±0.57)、血清ALT(82.81±4.75及68.70±5.81)U/L及AST活性(173.56±6.30及119.92±4.58)U/L显著高于对照组[57.48±0.53,(33.58±5.68)U/L、(85.84±5.20)U/L](P<0.01);NAC保护组小鼠肝指数、血清ALT及AST活性明显低于肝损伤组(P<0.01);与对照组(0.83±0.12、125.56±5.36)比较,肝损伤组小鼠MDA含量[(3.22±0.17)nmol/mgprot]显著升高,SOD活性[(88.44±5.52)U/mgprot]显著降低(P<0.01);与肝损伤组比较,NAC保护组MDA含量[(1.78±0.27)nmol/mgprot]明显降低,SOD活性[(106.85±3.66)U/mgprot]明显升高(P<0.01)。结论:异烟肼与利福平联合应用能引起小鼠较严重的肝损伤,N-乙酰半胱氨酸能够减轻这种损伤作用,其保护机制可能与增加机体谷胱甘肽(GSH)含量,从而减轻脂质过氧化反应有关

References

[1]  Sodhi CP,Rana SV,Mehta SK,et al.Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats[J].Drug Chem Toxicol,1997,20(3):255-269.
[2]  Flora SJ,Pande M,Kannan GM,et al.Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats[J].Cell Mol Biol(Noisy-le-grand),2004,50Online Pub:OL543-551.
[3]  Lailey AF.Oral N-acetylcysteine protects against perfluoroisobutene toxicity in rats[J].Hum Exp Toxicol,1997,16(4):212-216.
[4]  Lee EJ,Silva SM,Sim珘oes Mde J,et al.Effect of Nacetylcysteine in liver ischemia-reperfusion injury after30%hepatectomy in mice[J].Acta Cir Bras,2012,27(4):346-348.
[5]  Rana SV,Attri S,Vaiphei K,et al.Role of N-acetylcysteine in rifampicin-induced hepatic injury of young rats[J].World J Gastroenterol,2006,12(2):287-291.
[6]  Bonanomi L,Gazzaniga A.Toxicological,pharmacokinetic and metabolic studies on acetylcysteine[J].Eur J Respir Dis,1980,111:45-51.
[7]  夏愔愔,詹思延.国内抗结核药物不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423.
[8]  Attri S,Rana SV,Vaiphie K,et al.Protective effect of Nacetylcysteine in isoniazid induced hepatic injury in growing rats[J].Indian J Exp Biol,2001,39(5):436-440.
[9]  Singh M,Sasi P,Gupta VH,et al.Protective effect of curcumin,silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model[J].Hum Exp Toxicol,2012,31(8):788-797.
[10]  Romero FJ,Bosch-Morell F,Romero MJ,et al.Lipid peroxidation products and antioxidants in human disease[J].Environ Health Perspect,1998,106(Suppl5):1 229-1 234.
[11]  Njalsson R,Norgren S.Physiological and pathological aspects of GSH metabolism[J].Acta Paediatr,2005,94(2):132-137.
[12]  毕筱刚,李建国,周凤丽,等.N-乙酰半胱氨酸对缓解期肺心病的抗氧化和免疫调节作用[J].中国临床药学杂志,2001,10(5):275-276.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133